Cargando…
A Two-Year Treatment of Amnestic Mild Cognitive Impairment using a Compound Chinese Medicine: A Placebo Controlled Randomized Trail
We aimed to investigate the long-term therapeutic effects of a compound Chinese medicine, the Bushen capsule, on cognition and brain connectivity in patients with amnestic mild cognitive impairment (aMCI). Thus, sixty aMCI participants were recruited to this 24-month study and were randomly divided...
Autores principales: | Zhang, Junying, Liu, Zhen, Zhang, Huamin, Yang, Caishui, Li, He, Li, Xin, Chen, Kewei, Zhang, Zhanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931444/ https://www.ncbi.nlm.nih.gov/pubmed/27373556 http://dx.doi.org/10.1038/srep28982 |
Ejemplares similares
-
Corrigendum: A Two-Year Treatment of Amnestic Mild Cognitive Impairment using a Compound Chinese Medicine: A Placebo Controlled Randomized Trial
por: Zhang, Junying, et al.
Publicado: (2016) -
Multistage Grading of Amnestic Mild Cognitive Impairment: The Associated Brain Gray Matter Volume and Cognitive Behavior Characterization
por: Yang, Caishui, et al.
Publicado: (2017) -
Hippocampus-centred grey matter covariance networks predict the development and reversion of mild cognitive impairment
por: Dang, Mingxi, et al.
Publicado: (2023) -
Mismatch Negativity Latency as a Biomarker of Amnestic Mild Cognitive Impairment in Chinese Rural Elders
por: Ji, Li-Li, et al.
Publicado: (2015) -
Association of body mass index with amnestic and non-amnestic mild cognitive impairment risk in elderly
por: Wang, Feng, et al.
Publicado: (2017)